Doxorubicin Hydrochloride Injection, Solution
Product Images NDC 0143-9087

9 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 0143-9087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Doxorubicin HCl Injection Usp 1)

Structure (Doxorubicin HCl Injection Usp 1)
Chemical structure diagram of doxorubicin hydrochloride labeled with its molecular formula C27H29NO11·HCl and molecular weight 579.99. The diagram depicts the molecular arrangement of atoms in doxorubicin hydrochloride.*
FDA Label Image

Fig. 1 (Doxorubicin HCl Injection Usp 2)

Fig. 1 (Doxorubicin HCl Injection Usp 2)
A meta-analysis chart titled "Meta-analysis of Disease-Free Survival" showing hazard ratios with 95% confidence intervals for six clinical trials comparing doxorubicin-based treatments to CMF. The horizontal axis ranges from 0 to 2, with a vertical line at 1.0 indicating equivalence. Individual trial results are plotted as squares with confidence intervals, along with a diamond summarizing combined results. A dashed vertical line marks the boundary of non-inferiority with CMF at 1.06.*
FDA Label Image

Fig. 2 (Doxorubicin HCl Injection Usp 3)

Fig. 2 (Doxorubicin HCl Injection Usp 3)
A forest plot titled 'Figure 2. Meta-analysis of Overall Survival,' depicting hazard ratios with 95% confidence intervals for multiple clinical trials comparing Doxorubicin Hydrochloride-based treatments to CMF. The trials listed include NSABP B-15, SECSG 2, ONCOFRANCE, SE Sweden BCG A, NSABC Israel Br0283, Austrian BCSG 3, and a combined analysis of 6 Doxorubicin-based studies. The x-axis ranges from 0 to 2, indicating the survival benefit directionality, with 1 as the reference line.*
FDA Label Image

Vial (Doxorubicin HCl Injection Usp 4)

Vial (Doxorubicin HCl Injection Usp 4)
Label for Doxorubicin Hydrochloride Injection, USP, 10 mg per 5 mL (2 mg/mL) solution for intravenous use only. It is a preservative-free, sterile isotonic solution in a 5 mL single dose vial. The label includes dosage instructions, storage conditions (2° to 8°C), a warning about severe tissue damage if extravasated, and distributor information for Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Vial (Doxorubicin HCl Injection Usp 5)

Vial (Doxorubicin HCl Injection Usp 5)
Label for Doxorubicin Hydrochloride Injection, USP, 20 mg per 10 mL (2 mg/mL) intravenous solution. Single-dose 10 mL vial, preservative free, sterile isotonic solution. Manufactured by THYMOORGAN PHARMAZIE GmbH, Germany, and distributed by Hikma Pharmaceuticals USA Inc. Storage instructions specify refrigeration between 2° to 8°C and protection from light.*
FDA Label Image

Vial (Doxorubicin HCl Injection Usp 6)

Vial (Doxorubicin HCl Injection Usp 6)
Label for Doxorubicin Hydrochloride Injection, USP 50 mg per 25 mL (2 mg/mL) in a 25 mL single dose vial. The label states it is for intravenous use only, preservative free, and sterile isotonic solution. It includes storage instructions to refrigerate at 2° to 8°C and protect from light. Manufactured by THYMOORGAN PHARMAZIE GmbH, Germany, and distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Vial (Doxorubicin HCl Injection Usp 7)

Vial (Doxorubicin HCl Injection Usp 7)
Label of Doxorubicin Hydrochloride Injection, USP 2 mg/mL (200 mg per 100 mL) sterile isotonic solution for intravenous use only. The 100 mL multiple-dose vial is preservative-free. Manufacturer is THYMOORGAN PHARMAZIE GmbH, Germany, distributed by Hikma Pharmaceuticals USA Inc. Storage instructions include refrigeration and protection from light.*
FDA Label Image

Representative Carton Serialization Image (Doxorubicin HCl Injection Usp 8)

Representative Carton Serialization Image (Doxorubicin HCl Injection Usp 8)
Label for Doxorubicin Hydrochloride injection, solution, 2 mg/mL by Hikma Pharmaceuticals USA Inc. Displays GTIN, serial number (SN), expiration date (EXP), and lot number (LOT) with a QR code next to the text.*
FDA Label Image

Representative Carton Serialization Image (Doxorubicin HCl Injection Usp 9)

Representative Carton Serialization Image (Doxorubicin HCl Injection Usp 9)
Label for Doxorubicin Hydrochloride injection, solution, showing a 2D barcode and printed text fields for lot number, expiration date, GTIN, and serial number. The label includes placeholder text such as 'LOT ABCDE12345' and 'EXP MMMYYYY' and is associated with Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.